ArticleVaccines2022

Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus.

Ilaria Mormile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.